Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p 38 MAPK inhibition - Wen, J; Feng, Y; Huang, W; Chen, H; Liao, B; Rice, L; Preti, H A; Kamble, R T; Zu, Y; Ballon, D J; Chang, C C (Leuk Res, 2010)